Filter
452
Filtered Results: 452
Text search:
Ministry
of
Health
Singapore
Featured
Recommendations
35
New Publications
108
Language
Document type
No document type
219
Studies & Reports
81
Guidelines
80
Strategic & Response Plan
21
Manuals
16
Infographics
15
Fact sheets
7
Training Material
6
Situation Updates
5
Resource Platforms
2
Countries / Regions
Global
26
Myanmar / Burma
22
Singapore
19
India
15
Asia
14
Bangladesh
9
South–East Asia Region
8
Indonesia
7
Philippines
6
Nepal
5
Cambodia
5
Thailand
4
Syria
4
Nigeria
4
Western Pacific Region
4
Liberia
4
Kenya
3
Sierra Leone
3
Rwanda
3
Africa
3
Latin America and the Carribbean
3
Congo, Democratic Republic of
3
Brazil
3
China
2
Malawi
2
Guinea
2
Mozambique
2
Middle East and North Africa
2
Western and Central Europe
2
Bosnia and Herzegovina
2
Vietnam
2
Russia
2
Yemen
2
Ethiopia
2
Angola
2
South Sudan
2
Tajikistan
1
Mexico
1
El Salvador
1
Ghana
1
Kazakhstan
1
Cameroon
1
Albania
1
Laos
1
Senegal
1
Kyrgyzstan
1
Burkina Faso
1
Malaysia
1
Haiti
1
Guinea-Bissau
1
West and Central Africa
1
North America
1
Turkmenistan
1
France
1
Mauritius
1
Bolivia
1
Uganda
1
Eastern Europe
1
Moldova
1
Greece
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Countries
129
Public Health
35
Key Resources
34
Clinical Guidelines
30
Women & Child Health
15
Pharmacy & Technologies
9
Capacity Building
8
Toolboxes
COVID-19
92
Mental Health
47
Rapid Response
35
HIV
31
Disability
24
Planetary Health
16
Ebola & Marburg
12
AMR
12
Global Health Education
11
Caregiver
10
NTDs
10
TB
8
Health Financing Toolbox
8
NCDs
7
Refugee
6
Pharmacy
6
Natural Hazards
5
Zika
4
Cholera
2
Conflict
2
Polio
2
Specific Hazards
1
The second edition of the joint WHO, WIPO and WTO
publication “Promoting Access to Medical Technologies
and Innovation: Intersections between public health,
intellectual property and trade” (the Trilateral Study),*
published in 2020, included a special insert mappi...
Circulating vaccine-derived poliovirus type 2 in Angola
Ebola virus disease in Democratic Republic of the Congo
Dengue fever in Côte d’Ivoire
Humanitarian crisis in north-east Nigeria.
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform...
Guidelines for drinking-water quality: Fourth edition incorporating the first and second addenda
recommended
Guidance has been updated on a number of chemicals: asbestos, bentazone, chromium, iodine, manganese, microcystins, nickel, silver, tetrachloroethene and trichloroethene. Guidance has also been added for chemicals not previously assessed in the Guidelines: anatoxin-a and analogues, cylindrospermopsi...
This fourth annual report monitors global progress towards the 2023 target for global elimination of industrially produced trans-fatty acids (TFA), highlighting achievements during the past year (October 2021 – September 2022). Countries are responding to the World Health Organization (WHO) call t...
The Strategic Framework for Emergency Preparedness is a unifying framework which identifies the principles and elements of effective country health emergency preparedness. It adopts the major lessons of previous initiatives and lays out the planning and implementation process by which countries can ...
This fourth annual report monitors global progress towards the 2023 target for global elimination of industrially produced trans-fatty acids (TFA), highlighting achievements during the past year (October 2021 – September 2022). Countries are responding to the World Health Organization (WHO) call t...
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world.
In addition, this edition includes summary and recommendations from the virtual meeting of the members of the WHO Programme f...
Previous advocacy efforts have achieved tangible goals in terms garnering political commitments
to increase financing for TB—as seen at the 2018 UN High-Level Meeting on TB. The challenge
now is to ensure that these commitments are actually met within a global biomedical research
ecosystem that...
The plan contains the latest available evidence on the extent of insecticide resistance around the world, and puts forward a strategy for global and country levels, identifying clear roles and timelines for all stakeholders. The GPIRM also summarizes information about innovative new products being d...
The Regional Action Framework for Noncommunicable Disease Prevention and Control provides a unified vision of objectives and recommended actions to combat the noncommunicable disease (NCD) epidemic in the Western Pacific Region. Implementation should be supported by cross-sectoral coordination...
This guidance document has been produced by WHO to assist blood services in the development of national plans to respond to any emerging infectious threats to the sufficiency or safety of the blood supply, whether from an existing infectious agent that is changing in incidence and spread, or from a ...
COVID-19 has heavily emphasized how contact tracing is crucial for managing outbreaks, and as part of the strategy for adjusting, and eventually lifting, lockdowns and other stringent public health and social measures. As the pandemic develops further, it will be a core measure to manage further wav...
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
The response to a cholera outbreak must focus on limiting mortality and reducing the spread of the disease. It should be comprehensive and multisectoral, including epidemiology, case management, water, sanitation and hygiene, logistics, community engagement and risk communication. All efforts must b...
The workshop is structured around 13 learning modules. The first module (Introduction) gives an overview of WSPs. The last module (Module 12) introduces participants to the quality assurance tool for WSPs (WHO & IWA, 2012). Modules 1–11 relate explicitly to the WSP manual produced by IWA and WHO (...
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
This report presents country, regional and global estimates of low birth weight for 2000, together with a detailed description of the methods used in calculating the estimates. Some limited data on trends are also included. The limitations of low-birth-weight data are described and recommendations a...
Pandemic Influenza Risk Management
recommended
A WHO guide to inform & harmonize national & international pandemic preparedness and response
The main updates from the 2013 interim guidance are:
Alignment with other relevant United Nations policies for crisis and emergency management, and
Inclusion of the significant development in re...
